CIK 0001477449 · Large accelerated filer
Teladoc Health, Inc.
Sign in to watch- Ticker
- TDOC
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043705970
- Phone
- 2036352002
- Business address
- 155 E 44TH STREET, SUITE 1700, NEW YORK, NY, 10017
- Former names
- Teladoc, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $731,651
- in 9 filings, $369K under 10b5-1 plans
Net −$731,651. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Nueno Carlos −$310K President, International sold 50% of stake
- DIVITA CHARLES III −$224K CHIEF EXECUTIVE OFFICER sold 7% of stake
- Rodrigues Fernando M. −$98K President of BetterHelp sold 100% of stake
- Vandervoort Adam C −$48K CHIEF LEGAL OFFICER, SECRETARY sold 6% of stake
- Bliss Kelly −$46K President, U.S. Group Health sold 7% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-04 | Verstraete Stephany Chief Marketing Officer | Option exercise · Performance Stock Units | −4,811 | 4,811 | ||
| 2021-03-04 | Vandervoort Adam C Chief Legal Officer, Secretary | Sale | −970 | $200.48 | $194K | 5,806 |
| 2021-03-04 | Vandervoort Adam C Chief Legal Officer, Secretary | Option exercise | +3,455 | 9,261 | ||
| 2021-03-04 | Vandervoort Adam C Chief Legal Officer, Secretary | Option exercise | +4,489 | 13,750 | ||
| 2021-03-04 | Vandervoort Adam C Chief Legal Officer, Secretary | Option exercise · Restricted Stock Units | −3,455 | 3,454 | ||
| 2021-03-04 | Vandervoort Adam C Chief Legal Officer, Secretary | Option exercise · Performance Stock Units | −4,489 | 4,491 | ||
| 2021-03-04 | Turitz Andrew SVP - Business Development | Sale | −1,033 | $201.25 | $208K | 7,708 |
| 2021-03-04 | Turitz Andrew SVP - Business Development | Sale | −834 | $200.48 | $167K | 6,874 |
| 2021-03-04 | Turitz Andrew SVP - Business Development | Option exercise | +1,974 | 8,848 | ||
| 2021-03-04 | Turitz Andrew SVP - Business Development | Option exercise | +2,567 | 11,415 | ||
| 2021-03-04 | Turitz Andrew SVP - Business Development | Option exercise · Restricted Stock Units | −1,974 | 1,974 | ||
| 2021-03-04 | Turitz Andrew SVP - Business Development | Option exercise · Performance Stock Units | −2,567 | 2,567 | ||
| 2021-03-04 | Trencher Daniel SVP Corporate Strategy | Sale | −772 | $200.48 | $155K | 11,581 |
| 2021-03-04 | Trencher Daniel SVP Corporate Strategy | Option exercise | +1,974 | 13,555 | ||
| 2021-03-04 | Trencher Daniel SVP Corporate Strategy | Option exercise | +2,567 | 16,122 | ||
| 2021-03-04 | Trencher Daniel SVP Corporate Strategy | Option exercise · Restricted Stock Units | −1,974 | 1,974 | ||
| 2021-03-04 | Trencher Daniel SVP Corporate Strategy | Option exercise · Performance Stock Units | −2,567 | 2,567 | ||
| 2021-03-04 | GOREVIC JASON N Chief Executive Officer | Sale | −6,206 | $200.48 | $1.2M | 529,928 |
| 2021-03-04 | GOREVIC JASON N Chief Executive Officer | Option exercise | +16,777 | 546,705 | ||
| 2021-03-04 | GOREVIC JASON N Chief Executive Officer | Option exercise | +21,811 | 568,516 |
Page 76 of 93 · 1,848 trades